Stakeholder outcome prioritization in the Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK‐OFF JSpA) trial

Stakeholder outcome prioritization in the Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK‐OFF JSpA) trial

Abstract Background The Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK‐OFF JSpA) study is a randomized, pragmatic trial investigating different tumour necrosis factor inhibitor de‐escalation strategies for children with sustained inactive dise...

Full description

Bibliographic Details
Main Authors: Emily Neu, Cora Sears, Timothy Brandon, Melanie Kohlheim, Jenny Leal, Kweli Archie, English Holland, Miles Holland, Aamena Hameed, Asad Khan, Lynn Murphy, Sean Murphy, Antoinette Neu, Jerome Neu, Justin Neu, Rachel Richmond, Dylan Suplee, Theresa Suplee, Christopher B. Forrest, Pamela F. Weiss
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Health Expectations
Subjects:
patient‐reported outcomes
spondyloarthritis
stakeholder
trial
tumour necrosis factor inhibitors
Online Access:https://doi.org/10.1111/hex.13655

Internet

https://doi.org/10.1111/hex.13655

Similar Items